Notice for a Pre-application Webinar for Funding Opportunity Announcement PAR-18-947 "Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)"

Notice Number: NOT-CA-19-023

Key Dates
Release Date:January 31, 2019

Related Announcements

Issued by
National Cancer Institute (NCI)


The National Cancer Institute (NCI) will hold a public pre-application webinar on Thursday, February 7th, 2019, 1:00 PM-2:00 PM (EDT) for the Funding Opportunity Announcement (FOA) PAR-18-947: Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed).

The hyperlink to the FOA is:

This FOA has the following Application Due Dates:

March 14, 2019; July 11, 2019; November 7, 2019; March 11, 2020; July 9, 2020; November 9, 2020; March 15, 2021; July 11, 2021

Pre-Application Webinar

A public pre-application webinar will be held on Thursday, February 7th, 2019 at 1:00 p.m.- 2:00 p.m. (EDT) to provide information about the FOA to prospective applicants. NCI staff will provide an overview of the FOA and the application review process and answer questions from prospective applicants.

The webinar is open to all prospective applicants. Participation in this webinar, although encouraged, is optional and is not required for the submission of an application in response to PAR-18-947.

To join the webinar, follow the Webex link:

Audio connection:

1-650-479-3207 Call-in toll number (US/Canada)

Access code: 738 003 540


Please direct all inquiries to:

Lokesh Agrawal, Ph.D. 
National Cancer Institute (NCI)     
Telephone: 240-276-5718 

Abhi Rao, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-5715